November 10, 2025

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring an 11.91% Upside in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG) is making waves in the healthcare sector, particularly in the realm of medical care facilities. With a market capitalization of $10.42 billion, this U.S.-based..

Biogen Inc. (BIIB) Investor Outlook: Robust Pipeline and 13.64% Upside Potential

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, is generating buzz among investors due to its promising pipeline and significant upside potential. With a market capitalization of..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Unlocking Potential with an 88.10% Revenue Growth in Biotechnology

Avidity Biosciences, Inc. (NASDAQ: RNA), a prominent player in the biotechnology sector, is capturing the attention of investors with its intriguing blend of cutting-edge RNA therapeutics and a robust revenue..

Bausch + Lomb Corporation (BLCO) Stock Analysis: A Close Look at Its Modest Upside and Strategic Position in the Eye Health Industry

Investors with a keen focus on the healthcare sector, particularly in medical instruments and supplies, may find Bausch + Lomb Corporation (NYSE: BLCO) an intriguing prospect. With a market capitalization..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating the Potential Amidst Analyst Caution

Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the healthcare sector, is a company that has carved a niche in the diagnostics and research industry. With its comprehensive suite..

ICON plc (ICLR) Stock Analysis: Evaluating a 30% Upside Potential in the Healthcare Sector

The healthcare sector continues to draw significant investor attention, and ICON plc (NASDAQ: ICLR) stands out as a compelling player in the diagnostics and research industry. With its headquarters in..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with a Strong Return on Equity

Cencora, Inc. (NYSE: COR), previously known as AmerisourceBergen Corporation, stands as a formidable player in the healthcare sector, specifically in medical distribution. With a rich history dating back to 1871..

Rhythm Pharmaceuticals (RYTM) Investor Outlook: A Potential 21% Upside in the Biotech Frontier

Rhythm Pharmaceuticals, Inc. (RYTM), a burgeoning player in the biopharmaceutical industry, is garnering significant attention from investors with a potential upside of 21.07%, according to the latest analyst ratings. This..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Strong Growth and Strategic Partnerships Drive a 9.25% Potential Upside

For investors with an eye on the biotechnology sector, Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents a compelling opportunity. This San Diego-based biopharmaceutical company, with a market capitalization of $8.02 billion,..

Baxter International Inc. (BAX) Stock Analysis: Evaluating a 33.70% Potential Upside Amidst Financial Challenges

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, is currently navigating a complex financial landscape that presents both challenges and opportunities for investors. Operating from its..

Ascendis Pharma A/S (ASND) Stock Analysis: A 26% Upside Potential Amid Robust Revenue Growth

Investors looking for opportunities in the healthcare sector might find Ascendis Pharma A/S (NASDAQ: ASND) an intriguing proposition. This Denmark-based biopharmaceutical company, with a market capitalization of $11.97 billion, is..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating a 21% Potential Upside Amidst Biotech Challenges

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a prominent player in the biotechnology industry, specializing in RNA-targeted therapeutics and gene therapies. Despite its focus on pioneering treatments for debilitating rare diseases..

BrightSpring Health Services (BTSG) Stock Analysis: Exploring a 17.43% Potential Upside in Healthcare

BrightSpring Health Services, Inc. (BTSG) is capturing investor attention with its strong growth potential in the robust healthcare sector. As a key player in the Health Information Services industry, BrightSpring..

Repligen Corporation (RGEN) Investor Outlook: Unlocking a 30% Upside Potential in the Bioprocessing Market

Repligen Corporation (NASDAQ: RGEN) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Waltham, Massachusetts, Repligen has carved out a niche..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Market with a -25% Potential Downside

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare plans sector, operates with a mission to revolutionize the health insurance landscape through technology. As an American healthcare technology..

RadNet, Inc. (RDNT) Investor Outlook: A Promising Healthcare Contender with 4.92% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a leading provider of outpatient diagnostic imaging services, is making waves in the healthcare sector. With a market cap of $6.04 billion, RadNet is a significant..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 25% Potential Upside in Healthcare Diagnostics

Revvity, Inc. (RVTY), a prominent player in the healthcare sector specializing in diagnostics and research, offers an intriguing investment opportunity with a potential upside of 25.21%. Headquartered in Waltham, Massachusetts,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 13.89% Upside Potential Amidst Market Challenges

Bio-Rad Laboratories, Inc. (NYSE: BIO), a leading player in the healthcare sector, is at the forefront of the medical devices industry. With a market capitalization of $8.24 billion, Bio-Rad has..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating the Complexities of a High-Risk, High-Reward Proposition

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is a unique player in the healthcare sector, particularly in the niche of drug manufacturers focusing on specialty and generic products. Based in Hong..

Masimo Corporation (MASI) Stock Analysis: Exploring a 30% Potential Upside in the Medical Devices Sector

Masimo Corporation (NASDAQ: MASI), a leading player in the healthcare sector, focuses on developing cutting-edge patient monitoring technologies and connectivity solutions. With a market capitalization of $7.69 billion, Masimo stands..

Search

Funds

November 10, 2025

Search

Funds

November 10, 2025

FTSE 100

Funds